喉癌相关预后因素及临床治疗研究现状
Research Status of Prognostic Factors and Clinical Treatment of Laryngeal Cancer
DOI: 10.12677/acm.2025.152359, PDF,   
作者: 孙金迪:延安大学医学院,陕西 延安;柳林整*:榆林市第一医院耳鼻咽喉头颈外科,陕西 榆林
关键词: 喉癌预后因素治疗Laryngeal Cancer Prognostic Factors Treatment
摘要: 喉癌是常见的恶性肿瘤,其发病率和死亡率较高,预后和生存质量较差,因此探索其预后因素并制定个体化治疗策略至关重要。本文从患者、肿瘤及治疗手段三方面综述喉癌相关预后因素及临床治疗研究现状。患者因素包括性别、年龄、不良嗜好、职业暴露及HPV感染等;肿瘤因素涉及病理学、TNM分期、颈淋巴结转移及远处转移等;治疗手段涵盖手术、放疗、化疗、靶向治疗及术后护理和康复等。喉癌发病率呈上升趋势,多种危险因素与癌变机制相关性待明确。手术是主要治疗手段之一,放疗和全身治疗等非手术选项也可行,未来将向多专业参与和多学科团队诊疗发展,以制定个体化治疗策略,提高患者生存质量。
Abstract: Laryngeal cancer is a common malignant tumor with high morbidity and mortality, and poor prognosis and quality of life. Therefore, it is crucial to explore its prognostic factors and develop individualized treatment strategies. This article reviews the current research status of prognostic factors and clinical treatment of laryngeal cancer from three aspects: patient, tumor, and treatment methods. Patient factors include gender, age, bad habits, occupational exposure, and HPV infection; tumor factors involve pathology, TNM staging, cervical lymph node metastasis, and distant metastasis; treatment methods include surgery, radiotherapy, chemotherapy, targeted therapy, postoperative care, and rehabilitation. The incidence of laryngeal cancer is on the rise, and the correlation between many risk factors and carcinogenesis mechanism remains to be clarified. Surgery is one of the main treatment methods, and non-surgical options such as radiotherapy and systemic treatment are also feasible. In the future, it will develop towards multi-professional participation and multidisciplinary team diagnosis and treatment to formulate individualized treatment strategies and improve the quality of life of patients.
文章引用:孙金迪, 柳林整. 喉癌相关预后因素及临床治疗研究现状[J]. 临床医学进展, 2025, 15(2): 396-403. https://doi.org/10.12677/acm.2025.152359

参考文献

[1] Fu, Z. and Lv, J. (2024) A Commentary on “Updated Disease Distributions, Risk Factors, and Trends of Laryngeal Cancer: A Global Analysis of Cancer Registries”. International Journal of Surgery, 110, 4435-4436. [Google Scholar] [CrossRef] [PubMed]
[2] Aupérin, A. (2020) Epidemiology of Head and Neck Cancers: An Update. Current Opinion in Oncology, 32, 178-186. [Google Scholar] [CrossRef] [PubMed]
[3] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30. [Google Scholar] [CrossRef] [PubMed]
[5] Nocini, R., Molteni, G., Mattiuzzi, C. and Lippi, G. (2020) Updates on Larynx Cancer Epidemiology. Chinese Journal of Cancer Research, 32, 18-25. [Google Scholar] [CrossRef] [PubMed]
[6] 王雨欣, 朱文鹏, 韩梦琦, 等. 1990-2019年中国喉癌发病与死亡的趋势及预测研究[J]. 长治医学院学报, 2024, 38(1): 7-11.
[7] Tsur, N., Zloczower, E., Tunik, M., Amir, I., Yosefof, E., Havakuk, H.S., et al. (2024) Gender‐Related Aspects of Laryngeal Squamous Cell Carcinoma: A Retrospective Cohort Study. Clinical Otolaryngology, 49, 765-775. [Google Scholar] [CrossRef] [PubMed]
[8] Li, H., Li, E.Y. and Kejner, A.E. (2019) Treatment Modality and Outcomes in Larynx Cancer Patients: A Sex‐Based Evaluation. Head & Neck, 41, 3764-3774. [Google Scholar] [CrossRef] [PubMed]
[9] Shoffel‐Havakuk, H., O'Dell, K., Johns, M.M., Reder, L., Popova, M., Halperin, D., et al. (2019) The Rising Rate of Nonsmokers among Laryngeal Carcinoma Patients: Are We Facing a New Disease? The Laryngoscope, 130, E108-E115. [Google Scholar] [CrossRef] [PubMed]
[10] Zeng, H., Zheng, R., Sun, K., Zhou, M., Wang, S., Li, L., et al. (2024) Cancer Survival Statistics in China 2019-2021: A Multicenter, Population-Based Study. Journal of the National Cancer Center, 4, 203-213. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, B., Zhan, Z., Fang, W., Zheng, Y., Yu, S., Huang, J., et al. (2024) Long-Term Trends and Future Projections of Larynx Cancer Burden in China: A Comprehensive Analysis from 1990 to 2030 Using GBD Data. Scientific Reports, 14, Article No. 26523. [Google Scholar] [CrossRef] [PubMed]
[12] Zuo, J., Tao, Z., Chen, C., Hu, Z., Xu, Y., Zheng, A., et al. (2016) Characteristics of Cigarette Smoking without Alcohol Consumption and Laryngeal Cancer: Overall and Time-Risk Relation. a Meta-Analysis of Observational Studies. European Archives of Oto-Rhino-Laryngology, 274, 1617-1631. [Google Scholar] [CrossRef] [PubMed]
[13] Markou, K., Christoforidou, A., Karasmanis, I., et al. (2013) Laryngeal Cancer: Epidemiological Data from Northern Greece and Review of the Literature. Hippokratia, 17, 313-318.
[14] IARC Working Group on the Evaluation of Carcinogenic Risks to Human. (2010) Alcohol consumption and ethyl carbamate. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 96, 3-1383.
[15] Menvielle, G., Fayossé, A., Radoï, L., Guida, F., Sanchez, M., Carton, M., et al. (2015) The Joint Effect of Asbestos Exposure, Tobacco Smoking and Alcohol Drinking on Laryngeal Cancer Risk: Evidence from the French Population-Based Case-Control Study, Icare. Occupational and Environmental Medicine, 73, 28-33. [Google Scholar] [CrossRef] [PubMed]
[16] Paget-Bailly, S., Cyr, D. and Luce, D. (2012) Occupational Exposures and Cancer of the Larynx—Systematic Review and Meta-Analysis. Journal of Occupational & Environmental Medicine, 54, 71-84. [Google Scholar] [CrossRef] [PubMed]
[17] Peng, W., Mi, J. and Jiang, Y. (2015) Asbestos Exposure and Laryngeal Cancer Mortality. The Laryngoscope, 126, 1169-1174. [Google Scholar] [CrossRef] [PubMed]
[18] Hidalgo-Tenorio, C., Calle-Gómez, I., Moya-Megías, R., Rodríguez-Granges, J., Omar, M., López Hidalgo, J., et al. (2023) HPV Infection of the Oropharyngeal, Genital and Anal Mucosa and Associated Dysplasia in People Living with HIV. Viruses, 15, Article No. 1170. [Google Scholar] [CrossRef] [PubMed]
[19] Erkul, E., Yilmaz, I., Narli, G., Babayigit, M.A., Gungor, A. and Demirel, D. (2017) The Presence and Prognostic Significance of Human Papillomavirus in Squamous Cell Carcinoma of the Larynx. European Archives of Oto-Rhino-Laryngology, 274, 2921-2926. [Google Scholar] [CrossRef] [PubMed]
[20] 陈文杰, 王斌全, 高伟, 等. 喉癌流行病学特征及影响因素分析[J]. 中国当代医药, 2015, 22(12): 43-46.
[21] Liu, J.C., Bhayani, M., Kuchta, K., Galloway, T. and Fundakowski, C. (2019) Patterns of Distant Metastasis in Head and Neck Cancer at Presentation: Implications for Initial Evaluation. Oral Oncology, 88, 131-136. [Google Scholar] [CrossRef] [PubMed]
[22] Nocini, R., Sanchis-Gomar, F., Lippi, G. and Mattiuzzi, C. (2023) Red Blood Cell Distribution Width (RDW) Is a Significant Predictor of Survival in Laryngeal Cancer Patients: Systematic Literature Review and Meta-Analysis. Journal of Medical Biochemistry, 42, 557-564. [Google Scholar] [CrossRef] [PubMed]
[23] Lechien, J.R. (2024) Surgical, Functional, and Oncological Outcomes of Transoral Robotic Surgery for cT1-T3 Supraglottic Laryngeal Cancers: A Systematic Review. Oral Oncology, 159, Article ID: 107047. [Google Scholar] [CrossRef] [PubMed]
[24] Hartl, D.M. and Brasnu, D.F. (2015) Contemporary Surgical Management of Early Glottic Cancer. Otolaryngologic Clinics of North America, 48, 611-625. [Google Scholar] [CrossRef] [PubMed]
[25] Piazza, C., Paderno, A., Grazioli, P., Del Bon, F., Montalto, N., Perotti, P., et al. (2017) Laryngeal Exposure and Margin Status in Glottic Cancer Treated by Transoral Laser Microsurgery. The Laryngoscope, 128, 1146-1151. [Google Scholar] [CrossRef] [PubMed]
[26] Leone, C.A., Capasso, P., Topazio, D. and Russo, G. (2016) Supracricoid Laryngectomy for Recurrent Laryngeal Cancer after Chemoradiotherapy: A Systematic Review and Meta-Analysis. Acta Otorhinolaryngologica Italica, 36, 439-449. [Google Scholar] [CrossRef] [PubMed]
[27] Patel, S.A., Qureshi, M.M., Dyer, M.A., Jalisi, S., Grillone, G. and Truong, M.T. (2019) Comparing Surgical and Nonsurgical Larynx‐Preserving Treatments with Total Laryngectomy for Locally Advanced Laryngeal Cancer. Cancer, 125, 3367-3377. [Google Scholar] [CrossRef] [PubMed]
[28] Biau, J., Pointreau, Y., Blanchard, P., Khampan, C., Giraud, P., Lapeyre, M., et al. (2022) Radiotherapy for Laryngeal Cancers. Cancer/Radiothérapie, 26, 206-212. [Google Scholar] [CrossRef] [PubMed]
[29] Nutting, C.M., Morden, J.P., Harrington, K.J., Urbano, T.G., Bhide, S.A., Clark, C., et al. (2011) Parotid-Sparing Intensity Modulated versus Conventional Radiotherapy in Head and Neck Cancer (PARSPORT): A Phase 3 Multicentre Randomised Controlled Trial. The Lancet Oncology, 12, 127-136. [Google Scholar] [CrossRef] [PubMed]
[30] Trotti, A., Zhang, Q., Bentzen, S.M., Emami, B., Hammond, M.E., Jones, C.U., et al. (2014) Randomized Trial of Hyperfractionation versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512). International Journal of Radiation Oncology*Biology*Physics, 89, 958-963. [Google Scholar] [CrossRef] [PubMed]
[31] Merlotti, A., Alterio, D., Vigna-Taglianti, R., Muraglia, A., Lastrucci, L., Manzo, R., et al. (2014) Technical Guidelines for Head and Neck Cancer IMRT on Behalf of the Italian Association of Radiation Oncology—Head and Neck Working Group. Radiation Oncology, 9, Article No. 264. [Google Scholar] [CrossRef] [PubMed]
[32] Megwalu, U.C. and Sikora, A.G. (2014) Survival Outcomes in Advanced Laryngeal Cancer. JAMA Otolaryngology-Head & Neck Surgery, 140, 855-860. [Google Scholar] [CrossRef] [PubMed]
[33] Pfister, D.G., Spencer, S., Adelstein, D., Adkins, D., Anzai, Y., Brizel, D.M., et al. (2020) Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 18, 873-898. [Google Scholar] [CrossRef] [PubMed]
[34] Okumura, M., Motegi, A., Zenda, S., Nakamura, N., Hojo, H., Nakamura, M., et al. (2020) Efficacy and Safety of Accelerated Fractionated Radiotherapy without Elective Nodal Irradiation for T3N0 Glottic Cancer without Vocal Cord Fixation. Head & Neck, 42, 1775-1782. [Google Scholar] [CrossRef] [PubMed]
[35] The Cancer Genome Atlas Network (2015) Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas. Nature, 517, 576-582. [Google Scholar] [CrossRef] [PubMed]
[36] Kaye, R., Tang, C.G. and Sinclair, C.F. (2017) The Electrolarynx: Voice Restoration after Total Laryngectomy. Medical Devices: Evidence and Research, 10, 133-140. [Google Scholar] [CrossRef] [PubMed]
[37] Tang, C.G. and Sinclair, C.F. (2015) Voice Restoration after Total Laryngectomy. Otolaryngologic Clinics of North America, 48, 687-702. [Google Scholar] [CrossRef] [PubMed]